SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/13/15 -- (OTCQB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura long-term drug delivery technology, today reported financial results for the second qua ...
↧